January 12, 2017 “Is it in the public’s interest to have two similar cholesterol drugs on the market?” STAT, January 6, 2017 By: Leanne M. Rakers, Principal
June 21, 2018 Doug Robinson Parses Out Drug Patent Invalidation Rates with Law360 By: Douglas A. Robinson, Principal
January 9, 2019 Michael Teich Speaks to Law360 about new USPTO Computer Patent Guidance By: Michael L. Teich, Principal
July 9, 2013 “What We’ve Learned From 9 Months Of Inter Partes Reviews,” Law360, July 9, 2013 By: Matthew L. Cutler, Principal; Bryan K. Wheelock, Principal
December 21, 2020 Patent Attorney Michael Doerr Provides Pro Bono IP Counsel to Middle School Robotics Team By: Michael P. Doerr, Principal
